Azzad Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,496
| Closed | -$234K | – | 309 |
|
|
2024
Q1 | $234K | Buy |
8,496
+173
| +2% | +$4.76K | 0.03% | 290 |
|
|
2023
Q4 | $254K | Buy |
8,323
+571
| +7% | +$17.4K | 0.03% | 293 |
|
|
2023
Q3 | $245K | Buy |
7,752
+1,489
| +24% | +$47.1K | 0.03% | 292 |
|
|
2023
Q2 | $255K | Buy |
6,263
+454
| +8% | +$18.5K | 0.03% | 306 |
|
|
2023
Q1 | $217K | Sell |
5,809
-147
| -2% | -$5.48K | 0.03% | 307 |
|
|
2022
Q4 | $208K | Buy |
5,956
+87
| +1% | +$3.04K | 0.03% | 305 |
|
|
2022
Q3 | $328K | Sell |
5,869
-202
| -3% | -$11.3K | 0.03% | 368 |
|
|
2022
Q2 | $314K | Buy |
6,071
+590
| +11% | +$30.5K | 0.03% | 365 |
|
|
2022
Q1 | $398K | Sell |
5,481
-624
| -10% | -$45.3K | 0.06% | 285 |
|
|
2021
Q4 | $722K | Buy |
6,105
+150
| +3% | +$17.7K | 0.1% | 264 |
|
|
2021
Q3 | $799K | Sell |
5,955
-981
| -14% | -$132K | 0.12% | 252 |
|
|
2021
Q2 | $1.12M | Buy |
6,936
+210
| +3% | +$34K | 0.17% | 217 |
|
|
2021
Q1 | $540K | Buy |
+6,726
| New | +$540K | 0.09% | 271 |
|